Alpha Core Capital LLC Vista Gen Therapeutics, Inc. Transaction History

Alpha Core Capital LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $8,800 - $17,300	-10,000 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$1.14 - $2.09 $11,399 - $20,900	10,000 New	10,000 $12,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Alpha Core Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Core Capital LLC with notifications on news.